These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 19589678)

  • 21. Synthesis and cytotoxicity of racemic isodeoxypodophyllotoxin analogues with isoprene-derived side chains.
    Zhao Y; Feng JH; Ding HX; Xiong Y; Cheng CH; Hao XJ; Zhang YM; Pan YJ; Guéritte F; Wu XM; Bai H; Stöckigt J
    J Nat Prod; 2006 Aug; 69(8):1145-52. PubMed ID: 16933865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential proteomic analysis of HeLa cells treated with Honokiol using a quantitative proteomic strategy.
    Ling B; Liang SF; Xu YH; Zhao XY; Tang MH; Liu XY; Zhao X; Huang CH; Chen LJ; Wei YQ
    Amino Acids; 2008 Jun; 35(1):115-22. PubMed ID: 18157584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An expedient synthesis of honokiol and its analogues as potential neuropreventive agents.
    Tripathi S; Chan MH; Chen C
    Bioorg Med Chem Lett; 2012 Jan; 22(1):216-21. PubMed ID: 22142539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Honokiol produces anti-neoplastic effects on melanoma cells in vitro.
    Mannal PW; Schneider J; Tangada A; McDonald D; McFadden DW
    J Surg Oncol; 2011 Sep; 104(3):260-4. PubMed ID: 21472732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dibenzocyclooctadiene lignans overcome drug resistance in lung cancer cells--study of structure-activity relationship.
    Slaninová I; Brezinová L; Koubíková L; Slanina J
    Toxicol In Vitro; 2009 Sep; 23(6):1047-54. PubMed ID: 19531378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents.
    Wu M; Sun Q; Yang C; Chen D; Ding J; Chen Y; Lin L; Xie Y
    Bioorg Med Chem Lett; 2007 Feb; 17(4):869-73. PubMed ID: 17174089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of derrubone and select analogues.
    Hastings JM; Hadden MK; Blagg BS
    J Org Chem; 2008 Jan; 73(2):369-73. PubMed ID: 18154304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formylated honokiol analogs showed antitumor activity against lung carcinoma.
    Deng S; Zhang C; Yang L; Ma L
    Anticancer Drugs; 2019 Sep; 30(8):795-802. PubMed ID: 30807551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel 1,3,4-thiadiazole/oxadiazole-linked honokiol derivatives suppress cancer via inducing PI3K/Akt/mTOR-dependent autophagy.
    Xu T; Tian W; Zhang Q; Liu J; Liu Z; Jin J; Guo Y; Bai LP
    Bioorg Chem; 2021 Oct; 115():105257. PubMed ID: 34426156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenylpropanosids, lignans and other constituents from Cremanthodium ellisii.
    Wang AX; Zhang Q; Jia ZJ
    Pharmazie; 2004 Nov; 59(11):889-92. PubMed ID: 15587595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
    Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 23-oxa-analogues of OSW-1: efficient synthesis and extremely potent antitumor activity.
    Shi B; Wu H; Yu B; Wu J
    Angew Chem Int Ed Engl; 2004 Aug; 43(33):4324-7. PubMed ID: 15368382
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis, cytotoxicity and SAR of simple geiparvarin analogues.
    Valenti P; Rampa A; Recanatini M; Bisi A; Belluti F; Da Re P; Carrara M; Cima L
    Anticancer Drug Des; 1997 Sep; 12(6):443-51. PubMed ID: 9311554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-tumor effect of tanshinone II A, tetrandrine, honokiol, curcumin, oridonin and paeonol on leukemia cell lines].
    Shan QQ; Gong YP; Guo Y; Lin J; Zhou RQ; Yang X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):362-6. PubMed ID: 22812238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Facile purification of honokiol and its antiviral and cytotoxic properties.
    Amblard F; Delinsky D; Arbiser JL; Schinazi RF
    J Med Chem; 2006 Jun; 49(11):3426-7. PubMed ID: 16722664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antiproliferative evaluation of 4-anilino-n-methoxyfuro[2,3-b]quinoline derivatives (n=6, 7). Part 5.
    Chen YL; Lin HC; Yang CN; Lu PJ; Tzeng CC
    Chem Biodivers; 2008 Feb; 5(2):267-78. PubMed ID: 18293440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo.
    Bonner MY; Karlsson I; Rodolfo M; Arnold RS; Vergani E; Arbiser JL
    Oncotarget; 2016 Mar; 7(11):12857-68. PubMed ID: 26871475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and anti-neuroinflammatory activity of N-heterocyclic analogs based on natural biphenyl-neolignan honokiol.
    Yuan Y; Subedi L; Lim D; Jung JK; Kim SY; Seo SY
    Bioorg Med Chem Lett; 2019 Jan; 29(2):329-333. PubMed ID: 30472026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of C-12' substituted vinflunine derivatives.
    Lei XS; Yu XD; Yin L; Liu ZH; Tang PC
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4602-5. PubMed ID: 18653334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.